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ABSTRACT
Background: Children hospitalized with severe acute malnutrition
(SAM) have poor long-term outcomes following discharge, with high
rates of mortality, morbidity, and impaired neurodevelopment. There
is currently minimal guidance on how to support children with SAM
following discharge from inpatient treatment.
Objectives: This systematic review and meta-analysis aimed to
examine whether postdischarge interventions can improve outcomes
in children recovering from complicated SAM.
Methods: Systematic searches of 4 databases were undertaken to
identify studies of interventions delivered completely or partially
after hospital discharge in children aged 6–59 mo, following inpatient
treatment of SAM. The main outcome of interest was mortality.
Random-effects meta-analysis was undertaken where ≥2 studies
were sufficiently similar in intervention and outcome.
Results: Ten studies fulfilled the inclusion criteria, recruiting 39–
1781 participants in 7 countries between 1975 and 2015. Studies
evaluated provision of zinc (2 studies), probiotics or synbiotics
(2 studies), antibiotics (1 study), pancreatic enzymes (1 study),
and psychosocial stimulation (4 studies). Six studies had unclear
or high risk of bias in ≥2 domains. Compared with standard
care, pancreatic enzyme supplementation reduced inpatient mortality
(37.8% compared with 18.6%, P < 0.05). In meta-analysis there
was some evidence that prebiotics or synbiotics reduced mortality
(RR: 0.72; 95% CI: 0.51, 1.00; P = 0.049). Psychosocial stimulation
reduced mortality in meta-analysis of the 2 trials reporting deaths
(RR: 0.36; 95% CI: 0.15, 0.87), and improved neurodevelopmental
scores in ≥1 domain in all studies. There was no evidence that zinc
reduced mortality in the single study reporting deaths. Antibiotics
reduced infectious morbidity but did not reduce mortality.
Conclusions: Several biological and psychosocial interventions
show promise in improving outcomes in children following hospital-
ization for SAM and require further exploration in larger randomized
mortality trials. This study was registered with PROSPERO as
CRD42018111342 (https://www.crd.york.ac.uk/prospero/display_r
ecord.php?RecordID=111342). Am J Clin Nutr 2021;00:1–12.
Keywords: children, severe acute malnutrition, mortality, discharge,
hospitalization, interventions
Introduction
Severe acute malnutrition (SAM) is an important cause
of childhood mortality and morbidity in low- and middle-
income countries in children aged <5 y (1). Children with
“complicated” SAM [those with medical complications, an
Integrated Management of Childhood Illness (IMCI) danger sign,
severe edema, or who fail an appetite test], require inpatient
management according to WHO guidelines (2), with discharge
to outpatient care when clinical improvement is seen. Children
receive ready-to-use therapeutic food (RUTF) at home, with
discharge from community programs when nutritional recovery
has occurred.
Children leaving hospital following management of compli-
cated SAM have a high ongoing risk of mortality. A systematic
review examined outcomes 6–24 mo following discharge from
inpatient or outpatient treatment for SAM (3). In the 7 included
studies, mortality in children discharged as nutritionally cured
was ≤10% during follow-up. Another review reported relapse
rates of up to 37%, particularly in the first 6 mo following
discharge (4). The Chronic Disease Outcomes after Severe Acute
Malnutrition in Malawian Children (ChroSAM) study followed
children hospitalized with SAM several years after discharge, and
reported persistent growth and functional deficits compared with
sibling and community controls (5).
Current interventions following hospital discharge are limited
to short-term RUTF, but the existing data highlight the ongoing
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risk of mortality and relapse in children recovering from SAM.
Further interventions during the long window of postdischarge
vulnerability could reduce mortality and promote recovery. This
systematic review and meta-analysis was undertaken to evaluate
the existing evidence for interventions aimed at improving
postdischarge outcomes in children treated for complicated SAM.
Methods
Search strategy and study selection
PRISMA (Preferred Reporting Items for Systematic Reviews
and Meta-Analyses) guidelines were used throughout this
review, which followed a prespecified protocol registered with
PROSPERO (CRD42018111342). Systematic searches were
undertaken using Ovid-MEDLINE, Embase, Global Health, and
the Cochrane Central Register of Controlled Trials (CENTRAL)
in December 2018. The search strategy was formulated using
search terms and subject headings in 4 themes: child or infant,
severe acute malnutrition, trial or intervention, and inpatient or
discharge (see Supplemental Methods). Searches were limited
to English language articles published from 1970. The search
was repeated in December 2019 to identify new studies. In
addition, clinicaltrials.gov was searched to identify any further
trials or protocols, with a repeat search in January 2020. Searches
of the gray literature used the following websites: No Wasted
Lives, WHO, UNICEF, www.ennonline.net, and www.acutemal
nutrition.org. Five experts were contacted for unpublished data
or relevant studies not already identified. Reference lists of
shortlisted articles were examined to identify additional studies.
If a relevant protocol was identified but no results found, attempts
were made to contact the authors for further information.
We included both randomized and nonrandomized trials, and
other study types with an appropriate comparison group. Eligible
studies included children aged between 6 and 59 mo, hospitalized
with SAM, and subsequently discharged. We accepted different
definitions of SAM, according to the criteria used by each study
at the time. Interventions could be biological or psychosocial
but had to be delivered after hospital discharge, even if they
were initiated in hospital. Our main outcome of interest was
mortality. Studies reporting other clinically relevant outcomes
of child health or development were included, whereas those
reporting only mechanistic or biochemical outcomes, or indirect
outcomes such as maternal depression, were not included.
Studies were excluded if children received nonresidential,
community-based outpatient care only (currently recommended
only for children with uncomplicated SAM). Studies including
children with both complicated and uncomplicated SAM were
excluded if the children with complicated SAM comprised <50%
or an unknown proportion of the total population, and could not
be analyzed separately.
To ensure that we identified approaches that are relevant in
the current era, interventions had to be supplemental or distinct
from current management, which comprises ambulatory care
and RUTF. Studies providing micronutrients in the pre-RUTF
era were excluded if the dose was the same or less than is
currently provided by RUTF (6) for the majority of children in the
study. Studies superseded by current guidelines (e.g., comparing
RUTF with local foods, or comparing a prolonged hospital stay
with ambulatory rehabilitation) were excluded. Noninferiority
studies comparing locally formulated RUTF with standard RUTF
were also excluded, because the aim was to identify new
interventions of benefit to an individual child, beyond current
approaches.
Data extraction and narrative synthesis
All studies were exported to EndNote for title and abstract
screening. Full texts were retrieved and screened for eligibility
by 1 reviewer (CCAN), using the inclusion and exclusion criteria
specified above. Any uncertainty over the study eligibility was
resolved through discussion with a second reviewer (AJP).
Data were extracted using a standardized proforma. Risk-of-
bias assessments used guidance from the Cochrane Handbook
for Systematic Reviews of Interventions (7) and from Cochrane
Effective Practice and Organisation of Care (EPOC) resources
(8). Risk of bias was assessed at the study level, but where
there were differences between the main outcomes, or at different
timepoints, these were reported separately.
Meta-analysis
We prespecified that we would undertake meta-analysis where
≥2 more studies had sufficiently similar interventions and
outcomes. We conducted a random-effects meta-analysis to
calculate a summary measure of effect (RR), with a 95% CI.
Heterogeneity was assessed using Cochran Q test and Higgins




Searches identified 11,456 unique records. Of the 299
full-text articles assessed for eligibility, 284 were excluded,
mainly because participants did not meet inclusion criteria or
interventions were confined to the inpatient period (Figure 1).
Fifteen articles were included in the review, representing 10
studies in 7 countries, which recruited between 39 and 1781
participants from 1975 to 2015 (Tables 1 and 2). Six studies
evaluated biomedical interventions: zinc (n = 2), probiotics
(n = 2), antibiotics (n = 1), and pancreatic enzymes (n = 1).
Four studies evaluated psychosocial stimulation.
Study characteristics
Five studies were undertaken in sub-Saharan Africa (2 in
Malawi, 1 in Kenya, 1 in Ethiopia, and 1 in Uganda), 4 in south
Asia (3 in Bangladesh and 1 in India), and 1 in the Caribbean
(Jamaica). Only 1 trial recruited children from >1 site. The
average age of participants ranged from 11 to 27 mo (mean =
16 mo). Four studies included children outside the target 6–59-
mo age range, with the youngest participant at 60 d and the
oldest at 168 mo. Of the 4 studies reporting HIV prevalence, 2
reported a prevalence of 46% and 1 of 13%, whereas the other
recruited HIV-negative children only. Seven studies reported
nutritional edema prevalence of 17% to 66% (mean = 46%); 1
study excluded children with edema.
The definition of SAM varied between studies. Only 2
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FIGURE 1 Study selection. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow chart of study selection.
(10) to define SAM. Three other studies used midupper arm
circumference (MUAC): 1 used a MUAC cutoff of 11.5 cm and
presence of edema only, whereas 2 studies used a MUAC cutoff
of 11 cm, as well as edema and a weight-for-height criterion
based on National Center for Health Statistics (NCHS) growth
curves (11). The remaining 5 studies recruited children based on
weight-for-age [1 using the Wellcome classification (12), 1 using
the Harvard Standard, and 3 using the NCHS growth curves].
Two of these studies used weight-for-age only, whereas 3 also
recruited children with edema, and 1 also used a weight-for-
height criterion.
The 4 most recent studies only admitted children with
complicated SAM, as per current WHO guidelines (1, 13).
Although not explicit, the other studies likely admitted all
children with SAM. It is unclear what proportion of children
in these studies would meet current criteria for hospitalization,
although there are some indications that allow comparison with
current practice. For example, Kerac et al. (14) stated that 50%
of admitted children received parenteral antibiotics, and 46% of
children were HIV-positive. Dutta et al. (15) included children
with watery diarrhea and some dehydration, although excluded
children with other systemic infections.
Trials reported primary outcomes of neurodevelopment
(n = 4), anthropometry (n = 3), diarrhea (n = 2), and mortality
(n = 1). A further 7 studies reported mortality; in 5/7 it was
prespecified as a secondary outcome. Eight of the 10 studies were
randomized; 5 of these were double-blind trials. Four involved
single-blind evaluations of all outcomes, and 1 had single-blind
evaluation for 1 outcome only. Follow-up periods ranged from 28
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if length <65 cm,
or edema
Yes
1MUAC, midupper arm circumference; NCHS, National Center for Health Statistics median for age; SAM, severe acute malnutrition; WAZ,
weight-for-age z-score; WfA, weight-for-age; WfH, weight-for-length/weight-for-height; WHO, World Health Organization guidelines; WHZ,
weight-for-height z-score.
Risk of bias
Two studies had a low risk of bias across all domains, and
2 studies had an unclear or high risk of bias in 1 domain only
(Table 3). The other 6 studies, including all 4 studies examining




One study evaluated prophylactic antibiotics. Berkley et al.
(25) undertook a placebo-controlled trial of daily co-trimoxazole
at 4 sites in Kenya, initiated during stabilization in hospital and
continued for 6 mo in HIV-negative children. Co-trimoxazole
reduced some infections, including malaria; however, there was
no difference in mortality between groups at 12 mo (14%
intervention compared with 15% placebo; RR: 0.91; 95% CI:
0.72, 1.14; Figure 2).
Pancreatic enzymes.
Bartels et al. (26) undertook a pilot study of pancreatic
enzymes, with children in the intervention group receiving
amylase, lipase, and protease 3 times daily for 28 d, compared
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outcome of weight change at 28 d. Mortality (a prespecified
secondary outcome) was significantly lower in the intervention
group (18.6% compared with 37.8%; P < 0.05), although all
deaths occurred in the inpatient period. A difference in the
proportion of children with edema in intervention and control
groups (69% compared with 44%, respectively) might have
contributed.
Zinc.
Two studies evaluated zinc at greater doses than RUTF; at
recommended dosing, current RUTF provides 4.7 mg/kg/d zinc
(6). Doherty et al. (21) gave 6 mg/kg/d zinc for 30 d (A), with 2
comparison groups receiving either 1.5 mg/kg/d (B) or 6 mg/kg/d
(C) zinc for 15 d, followed by placebo in both groups for 15
d. There was no difference in anthropometric measures between
groups. Combined inpatient and outpatient mortality was higher
in the 2 high-dose zinc groups (4% in B compared with 16% in
C compared with 21% in A). Children receiving zinc compared
with placebo from days 16 to 30 (group A compared with C) had
no evidence of reduced outpatient mortality (RR: 1.19; 95% CI:
0.25, 5.54; Figure 2). Dutta et al. (15) recruited male children
with acute watery diarrhea and “some dehydration.” They were
provided with either 40 mg/d (average ∼7 mg/kg/d) zinc from a
bottle, or placebo, with the bottle continued after discharge for
a maximum of 14 d. The intervention group had a significantly
shorter duration of inpatient diarrhea (70 compared with 103
h), but there were no significant differences in anthropometry
after 30 d. Mortality and outpatient diarrhea were not reported.
Meta-analysis of these 2 zinc studies was not undertaken because
zinc was provided for different durations during inpatient and
outpatient periods, and mortality was only reported in 1 study.
Probiotics/synbiotics.
Two studies evaluated probiotics or synbiotics. Kerac et al.
(14) in Malawi gave 4 probiotics and 4 prebiotics mixed with
RUTF, compared with a standard RUTF. There was no difference
between groups in nutritional cure, but there was a trend
toward reduced mortality in the intervention group following
discharge from the index hospitalization (14% compared with
19%; P = 0.05). Grenov et al. (27) in Uganda gave 1 sachet of 2
probiotics daily, compared with placebo, for 8–12 wk. There was
no difference between groups in the duration of diarrhea during
hospitalization (primary outcome), but the intervention group had
fewer days with diarrhea during outpatient treatment. Mortality
after hospital discharge was similar in the intervention (3/147;
2%) and control groups (4/145; 3%). In meta-analysis, there was
evidence that probiotics reduced mortality (RR: 0.72; 95% CI:
0.51, 1.00; P = 0.049; Figure 2).
Psychosocial interventions.
Four studies investigated psychosocial interventions (16–20,
22–24, 28). All studies provided stimulation through child
play therapy, together with parental education; interventions
were provided at a variable intensity during the outpatient
period. Three studies commenced stimulation sessions for the
intervention group in hospital (17, 22, 28). Two studies provided
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and outpatient clinics (22), and 1 provided outpatient clinics only
(23). All control groups received standard care only, with no
home visits. The number of outpatient contacts was higher for
intervention compared with control groups for 3 studies, and was
only similar between groups in the study not providing home
visits. All studies reported higher developmental scores in ≥1
domain in the intervention group, and 2 studies also reported
higher weight-for-age (22, 23). Two studies reported mortality,
which was not a prespecified outcome. In the study by Nahar
et al. (22), mortality was similar between the intervention (2/54;
4%) and control group (2/43; 5%). By contrast, in the study by
Abessa et al. (28), 5/145 (3%) children in the intervention group
died compared with 14/117 (12%) in the nonintervention group
(RR: 0.29; 95% CI: 0.11, 0.78). In meta-analysis, there was strong
evidence of an effect of psychosocial stimulation on mortality
(RR: 0.36; 95% CI: 0.15, 0.87; Figure 2).
Discussion
Children with complicated SAM have unacceptably high
mortality, morbidity, and relapse after discharge from hospital,
and long-term risks of impaired neurodevelopment (3–5). SAM
has multiple social, environmental, and biomedical determi-
nants and effective long-term management requires a holistic
approach. Current WHO guidelines provide current best practice
but predominantly focus on inpatient management, and there
are limited recommendations for postdischarge convalescence.
Approximately 10% of children die during the year after
discharge from nutritional care and there is a pressing need
for adjunctive interventions to reduce mortality. Our systematic
review identified 10 trials conducted over 40 y that evalu-
ated biomedical or psychosocial interventions after hospital
discharge. Two biomedical approaches showed some evidence
of mortality benefits: pancreatic enzyme supplementation (26),
and provision of synbiotics (14). Psychosocial interventions,
providing child stimulation and parental education of variable
intensity and duration, improved neurodevelopmental scores in
all studies (17, 22–24, 28) and significantly reduced mortality
in meta-analysis of 2 studies. Collectively these studies indicate
several promising biomedical and psychosocial strategies, and
the need for additional trials to evaluate novel approaches
to improving child survival, health, and development during
convalescence.
Pancreatic enzyme supplementation was evaluated in a single-
blind pilot study in Malawi (26). Pancreatic insufficiency
is common in SAM and is particularly severe in children
with edematous malnutrition (29). Lack of digestive enzyme
production causes protein and lipid malabsorption, thereby
impairing nutritional recovery. There was no difference in the
primary outcome of weight gain at 28 d but, unexpectedly,
mortality was significantly lower in the intervention group
(38% compared with 19%). There was no difference in fecal
elastase concentrations between groups, and all deaths occurred
in hospital in the first 14 d. It is therefore difficult to explain the
mechanism underlying the mortality benefit. One limitation in
interpretation is that the proportion of children with edematous
malnutrition was significantly higher in the intervention group.
It would be valuable to undertake a larger and longer random-







/ajcn/advance-article/doi/10.1093/ajcn/nqaa359/6124678 by guest on 31 January 2021
Interventions for complicated SAM 9
FIGURE 2 Effects of interventions on postdischarge mortality in children with severe acute malnutrition. Forest plot showing the effects of synbiotics or
probiotics, child stimulation, zinc, and co-trimoxazole on mortality after discharge from hospital. Combined effects are from a random-effects meta-analysis.
There is increasing evidence that the gut has a central role in
the pathogenesis of SAM, with alterations in intestinal structure,
integrity, and microbiome composition likely contributing (30,
31). Optimum interventions to improve gut function and to
treat acute and persistent diarrhea are unclear (32). Probiotics
might plausibly address enteropathy. There is some evidence
for their efficacy in reducing diarrhea in children, although
data from low-income countries and malnutrition are lacking
(33, 34). Of the 2 probiotic/synbiotic trials identified in our
review, one demonstrated ∼2 fewer days of outpatient diarrhea
(26% reduction) (27). The other, which gave prebiotics and
probiotics formulated into an RUTF, did not reduce diarrhea
overall, and severe inpatient diarrhea was increased (14). There
was no evidence of probiotic-related sepsis in either trial. In
meta-analysis there was some evidence that probiotics reduced
mortality, driven by lower postdischarge mortality in Malawi.
These findings suggest that probiotics show promise, but greater
clarity is needed on which species, dose, and duration to use,
particularly in low-income settings. Zinc is also a plausible gut-
focused intervention, evaluated in 2 trials. One trial reported that
zinc reduced diarrhea in the inpatient period (15), but neither
measured diarrhea after discharge. The other trial (21) reported
more deaths in the 2 groups receiving higher-dose zinc in the
first 15 d, with most appearing to be inpatient deaths from
sepsis. Higher-dose zinc had no mortality benefit compared with
placebo when continued after hospital discharge. The authors
hypothesized that zinc could have harmful effects on the immune
response during sepsis and could impede absorption of other
micronutrients. The dose of 6 mg/kg/d is higher than current
provision in RUTF (∼4.7 mg/kg/d) (6), and was likely started
earlier in treatment. Further understanding of the role of zinc in
SAM recovery is needed.
The largest trial investigated whether prophylactic co-
trimoxazole reduces mortality, because infections are the main
cause of death during recovery from SAM (30). Co-trimoxazole
was chosen because of its reported benefits in HIV-infected
children (35–38), and its immunomodulatory properties (39, 40).
However, co-trimoxazole prophylaxis for 6 mo postdischarge
did not improve mortality or growth outcomes in HIV-negative
children with SAM, although there was a lower incidence of
malaria and some bacterial infections (25). There is mixed
evidence for the benefit of short antibiotic courses in uncom-
plicated severe acute malnutrition, with reduced mortality and
increased nutritional recovery seen in Malawi (41) but not in
Niger, where the rates of HIV and edematous malnutrition were
much lower (42). Children discharged from hospital can be
colonized or infected with bacteria that are resistant to commonly
used antibiotics, and a different antimicrobial strategy could be
required to reduce severe bacterial infections, and other infections
including tuberculosis.
Global attention is increasingly moving beyond child survival,
to ensuring that children thrive. Sustainable Development Goal
4 (43) now includes a target for quality early childhood develop-
ment. There is evidence of a sustained detrimental impact of SAM
on developmental potential and long-term cognitive function,
which is exacerbated by psychosocial deprivation (44, 45). Child
play is included in the WHO guidelines for hospital management
of SAM, with advice that the caregiver continue the intervention
after discharge (2). Two randomized and 2 nonrandomized trials
examined the impact of delivering stimulation sessions through
child play together with parental education, either at home or in
clinics; all showed an improvement in ≥1 neurodevelopmental
domain. It is challenging to conduct high-quality, long-term
studies in SAM, and all 4 studies had a high risk of bias
in ≥2 domains, with substantial loss to follow-up and an
unclear risk of contamination. The interventions were of very
variable intensity (from 3 visits over 6 mo, to 1–2-weekly
sessions over 3 y), making comparability difficult. Of the 2 trials
reporting mortality, 1 showed significantly lower mortality in the
intervention group compared with the control group. Mortality
was not a prespecified outcome in this randomized trial, and the
mechanism underlying mortality reduction is uncertain, given
that there was no difference in anthropometry between groups
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reduces mortality, regardless of the content of the visits, needs
to be investigated, because the control group received standard
care without home visits. Collectively, it is evident from this
systematic review that psychosocial interventions improve long-
term outcomes in SAM, but the optimum nature, timing, and
intensity of intervention is unclear.
Several other relevant trials did not meet inclusion criteria
for our review. A cluster-randomized trial in the Democratic
Republic of Congo found that monthly cash transfers signifi-
cantly improved nutritional outcomes and reduced relapse at 6 mo
(46), due to improved dietary diversity and food security. Water
treatment packages implemented alongside outpatient therapeu-
tic feeding programs improved recovery from uncomplicated
SAM in Pakistan and Chad (47, 48). The causal pathway is
unclear, because there were no significant reductions in diarrhea.
Preliminary studies have adjusted RUTF composition to improve
ω-6 and ω-3 fatty acid balance (49–51), and given mesalazine
to treat enteropathy (52). Consideration has also been given
to the optimum timing of antiretroviral therapy initiation in
HIV-infected children during nutritional rehabilitation (53–56).
Finally, a package of health and nutrition interventions, including
lipid-based nutritional supplements, malaria chemoprophylaxis,
deworming, and zinc, given to children after completing moder-
ate acute malnutrition treatment, did not improve outcomes at 1 y
(57).
We sought to find interventions that were supplemental to
current SAM management, so that they would have relevance
to the current era. The SAM treatment “landscape” has evolved
over recent years, with the introduction of RUTF and community-
based management of acute malnutrition, and there is a large
body of research that has been superseded. For example, we
did not include studies that compared inpatient and home-based
rehabilitation, because home-based care after initial stabilization
has been established to be cost-effective and equally efficacious
in promoting nutritional recovery (58, 59). We did not discuss
studies comparing different forms of food supplementation
during home-based care, because provision of RUTF has been
established as best practice in WHO guidance (60–62). In
addition, there has recently been a focus on using locally
produced RUTF with alternative ingredients, to increase capacity
and reduce program costs (63–68). These topics were outside the
scope of this review.
Several biomedical and psychosocial approaches appear
promising and require further exploration in larger randomized
trials designed to assess mortality. SAM is a complex condition
with both medical and social components, and it is likely that
a holistic package of care is needed to address its multiple
determinants. We did not identify any studies that combined
both biomedical and psychosocial approaches. An enabling
environment is likely needed to promote effective recovery from
SAM, with interventions that address the root causes of poverty,
food insecurity, poor maternal physical and mental health, and
gendered household dynamics. Integrated care is a cornerstone
of child health, not just in SAM, as typified by the IMCI strategy
(69) and more recent Nurturing Care Framework (70). As such,
we would advocate for future convalescent packages of care to be
tested.
A key limitation of this review was the variation in definitions
of complicated SAM between studies. In addition, inpatient and
outpatient management was not always consistent with current
practice. Prior to availability of outpatient RUTF, children would
receive supervised milk feeds in hospital for longer durations than
currently, and would generally be discharged when they reached
a target weight, in contrast to current practice. We felt it was
important to include as many relevant studies as possible, but
there is likely an impact on the comparability of the studies and
their applicability to the current era. Another limitation is that
the interventions were of variable intensity and duration, with
some initiated early during hospitalization. Some key primary
outcomes were measured solely during the inpatient period, or
after very short follow-up periods. It was therefore difficult to
form conclusions about whether some interventions had longer-
term benefits. Over half the studies had a high or unclear risk
of bias, and trials varied in size, location, SAM definition,
HIV prevalence, primary outcome, and duration of follow-up,
meaning the findings of the review need to be interpreted with
caution.
In summary, there is currently limited evidence to inform
convalescence in children with complicated SAM following
discharge from hospital. Only 10 trials from the past 5 decades
met our inclusion criteria, despite the urgent need for new
approaches to reduce high postdischarge mortality. Several
biomedical and psychosocial approaches show promise, but
further exploration is required. It seems likely that a package
of interventions, including both biomedical and psychosocial
elements, would bring most benefit, in view of the multifaceted
factors underlying mortality following discharge from hospital in
this vulnerable population.
The author’ s responsibilities were as follows—CCAN, JPS, MB-D, BA,
PK, AJP: designed the research; CCAN, JPS: analyzed the data; CCAN, AJP:
wrote the first draft of the manuscript; AJP: had primary responsibility for the
final content; and all authors: read and approved the final manuscript.
The authors report no conflicts of interest.
Data Availability
Data described in the manuscript, code book, and analytic code
will be made available upon request.
References
1. World Health Organization. Guideline: updates on the management of
severe acute malnutrition in infants and children. Geneva: WHO; 2013.
2. World Health Organization. Guidelines for the inpatient treatment of
severely malnourished children. Geneva: WHO; 2003.
3. O’Sullivan N, Kerac M, James P. Follow-up between 6 and 24 months
after discharge from treatment for severe acute malnutrition in children
aged 6–59 months: a systematic review. Arch Dis Child 2018;103:A181.
4. Stobaugh HC, Mayberry A, McGrath M, Bahwere P, Zagre NM,
Manary MJ, Black R, Lelijveld N. Relapse after severe acute
malnutrition: a systematic literature review and secondary data analysis.
Matern Child Nutr 2019;15(2):e12702.
5. Lelijveld N, Seal A, Wells JC, Kirkby J, Opondo C, Chimwezi E,
Bunn J, Bandsma R, Heyderman RS, Nyirenda MJ, et al. Chronic
disease outcomes after severe acute malnutrition in Malawian children
(ChroSAM): a cohort study. Lancet Glob Health 2016;4(9):e654–62.
6. Nutriset Group. Severe acute malnutrition (treatment): plumpy nut
ready-to-use therapeutic food (RUTF) [Internet]. [cited July 14, 2020].
Available from: https://www.nutriset.fr/products/en/plumpy-nut.
7. Higgins JPT, Green S,editors. Cochrane handbook for systematic
reviews of interventions. Version 5.1.0 [Internet]. The Cochrane
Collaboration; March 2011 [cited July 7, 2020]. Available from: http:
//handbook-5-1.cochrane.org/.
8. Cochrane Effective Practice and Organisation of Care (EPOC). EPOC






/ajcn/advance-article/doi/10.1093/ajcn/nqaa359/6124678 by guest on 31 January 2021
Interventions for complicated SAM 11
[cited July 7, 2020]. Available from: http://epoc.cochrane.org/epoc-res
ources-review-authors.
9. World Health Organization. WHO child growth standards and the
identification of severe acute malnutrition in infants and children.
Geneva: WHO; 2009.
10. World Health Organization. WHO child growth standards. Geneva:
WHO; 2006.
11. Hamill PV, Drizd TA, Johnson CL, Reed RB, Roche AF. NCHS growth
curves for children birth–18 years. United States. Vital and health
statistics Series 11, Data from the National Health Survey; no. 165.
Hyattsville (MD): US Department of Health, Education, and Welfare;
1977. p. i–iv, 1-74.
12. Wellcome Trust Working Party. Classification of infantile malnutrition.
Lancet 1970;2(7667):302–3.
13. World Health Organization, World Food Programme, United Nations
System Standing Committee on Nutrition, The United Nations
Children’s Fund. Community-based management of severe acute
malnutrition: a joint statement by the World Health Organization,
the World Food Programme, the United Nations System Standing
Committee on Nutrition and the United Nations Children’s Fund. WHO;
2007.
14. Kerac M, Bunn J, Seal A, Thindwa M, Tomkins A, Sadler K, Bahwere
P, Collins S. Probiotics and prebiotics for severe acute malnutrition
(PRONUT study): a double-blind efficacy randomised controlled trial
in Malawi. Lancet 2009;374(9684):136–44.
15. Dutta P, Mitra U, Datta A, Niyogi SK, Dutta S, Manna B, Basak
M, Mahapatra TS, Bhattacharya SK. Impact of zinc supplementation
in malnourished children with acute watery diarrhoea. J Trop Pediatr
2000;46(5):259–63.
16. Grantham-McGregor S, Stewart M, Powell C, Schofield WN. Effect
of stimulation on mental development of malnourished child. Lancet
1979;2(8135):200–1.
17. Grantham-McGregor S, Stewart ME, Schofield WN. Effect of long-
term psychosocial stimulation on mental development of severely
malnourished children. Lancet 1980;2(8198):785–9.
18. Grantham-McGregor S, Schofield W, Harris L. Effect of psychosocial
stimulation on mental development of severely malnourished children:
an interim report. Pediatrics 1983;72(2):239–43.
19. Grantham-McGregor S, Schofield W, Powell C. Development of
severely malnourished children who received psychosocial stimulation:
six-year follow-up. Pediatrics 1987;79(2):247–54.
20. Grantham-McGregor S, Powell C, Walker S, Chang S, Fletcher P.
The long-term follow-up of severely malnourished children who
participated in an intervention program. Child Dev 1994;65(2 Spec
No.):428–39.
21. Doherty CP, Sarkar MA, Shakur MS, Ling SC, Elton RA, Cutting WA.
Zinc and rehabilitation from severe protein-energy malnutrition: higher-
dose regimens are associated with increased mortality. Am J Clin Nutr
1998;68(3):742–8.
22. Nahar B, Hamadani JD, Ahmed T, Tofail F, Rahman A, Huda
SN, Grantham-McGregor SM. Effects of psychosocial stimulation
on growth and development of severely malnourished children
in a nutrition unit in Bangladesh. Eur J Clin Nutr 2009;63(6):
725–31.
23. Hossain MI, Nahar B, Hamadani JD, Ahmed T, Brown KH. Effects
of community-based follow-up care in managing severely underweight
children. J Pediatr Gastroenterol Nutr 2011;53(3):310–19.
24. Nahar B, Hossain MI, Hamadani JD, Ahmed T, Grantham-McGregor
S, Persson LA. Effects of psychosocial stimulation on improving home
environment and child-rearing practices: results from a community-
based trial among severely malnourished children in Bangladesh. BMC
Public Health 2012;12:622.
25. Berkley JA, Ngari M, Thitiri J, Mwalekwa L, Timbwa M, Hamid F,
Ali R, Shangala J, Mturi N, Jones KD, et al. Daily co-trimoxazole
prophylaxis to prevent mortality in children with complicated severe
acute malnutrition: a multicentre, double-blind, randomised placebo-
controlled trial. Lancet Glob Health 2016;4(7):e464–73.
26. Bartels RH, Bourdon C, Potani I, Mhango B, van den Brink DA,
Mponda JS, Muller Kobold AC, Bandsma RH, Boele van Hensbroek
M, Voskuijl WP. Pancreatic enzyme replacement therapy in children
with severe acute malnutrition: a randomized controlled trial. J Pediatr
2017;190:85–92.e2.
27. Grenov B, Namusoke H, Lanyero B, Nabukeera-Barungi N, Ritz C,
Molgaard C, Friis H, Michaelsen KF. Effect of probiotics on diarrhea in
children with severe acute malnutrition: a randomized controlled study
in Uganda. J Pediatr Gastroenterol Nutr 2017;64(3):396–403.
28. Abessa TG, Worku BN, Wondafrash M, Girma T, Valy J, Lemmens
J, Bruckers L, Kolsteren P, Granitzer M. Effect of play-based
family-centered psychomotor/psychosocial stimulation on the
development of severely acutely malnourished children under six in a
low-income setting: a randomized controlled trial. BMC Pediatr
2019;19(1):336.
29. Bartels RH, Meyer SL, Stehmann TA, Bourdon C, Bandsma
RHJ, Voskuijl WP. Both exocrine pancreatic insufficiency and
signs of pancreatic inflammation are prevalent in children with
complicated severe acute malnutrition: an observational study. J Pediatr
2016;174:165–70.
30. Jones KD, Thitiri J, Ngari M, Berkley JA. Childhood malnutrition:
toward an understanding of infections, inflammation, and
antimicrobials. Food Nutr Bull 2014;35(2 Suppl):S64–70.
31. Amadi B, Besa E, Zyambo K, Kaonga P, Louis-Auguste J, Chandwe
K, Tarr PI, Denno DM, Nataro JP, Faubion W, et al. Impaired barrier
function and autoantibody generation in malnutrition enteropathy in
Zambia. EBioMedicine 2017;22:191–9.
32. Kelly P, Bell L, Amadi B, Bwakura-Dangarembizi M, VanBuskirk K,
Chandwe K, Chipunza M, Ngosa D, Chulu N, Hill S, et al. TAME trial:
a multi-arm phase II randomised trial of four novel interventions for
malnutrition enteropathy in Zambia and Zimbabwe – a study protocol.
BMJ Open 2019;9(11):e027548.
33. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for
treating acute infectious diarrhoea. Cochrane Database Syst Rev
2010(11):CD003048.
34. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE.
Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis
of masked, randomised, placebo-controlled trials. Lancet Infect Dis
2006;6(6):374–82.
35. Chintu C, Bhat GJ, Walker AS, Mulenga V, Sinyinza F, Lishimpi
K, Farrelly L, Kaganson N, Zumla A, Gillespie SH, et al. Co-
trimoxazole as prophylaxis against opportunistic infections in HIV-
infected Zambian children (CHAP): a double-blind randomised
placebo-controlled trial. Lancet 2004;364(9448):1865–71.
36. Mulenga V, Ford D, Walker AS, Mwenya D, Mwansa J, Sinyinza
F, Lishimpi K, Nunn A, Gillespie S, Zumla A, et al. Effect of
cotrimoxazole on causes of death, hospital admissions and antibiotic
use in HIV-infected children. AIDS 2007;21(1):77–84.
37. Prendergast A, Walker AS, Mulenga V, Chintu C, Gibb DM.
Improved growth and anemia in HIV-infected African children
taking cotrimoxazole prophylaxis. Clin Infect Dis 2011;52(7):
953–6.
38. Bwakura-Dangarembizi M, Kendall L, Bakeera-Kitaka S, Nahirya-
Ntege P, Keishanyu R, Nathoo K, Spyer MJ, Kekitiinwa A, Lutaakome
J, Mhute T, et al. A randomized trial of prolonged co-trimoxazole
in HIV-infected children in Africa. N Engl J Med 2014;370(1):
41–53.
39. Church JA, Fitzgerald F, Walker AS, Gibb DM, Prendergast AJ. The
expanding role of co-trimoxazole in developing countries. Lancet Infect
Dis 2015;15(3):327–39.
40. Bourke CD, Gough EK, Pimundu G, Shonhai A, Berejena C, Terry
L, Baumard L, Choudhry N, Karmali Y, Bwakura-Dangarembizi M,
et al. Cotrimoxazole reduces systemic inflammation in HIV infection
by altering the gut microbiome and immune activation. Sci Transl Med
2019;11(486):aav0537.
41. Trehan I, Goldbach HS, LaGrone LN, Meuli GJ, Wang RJ, Maleta KM,
Manary MJ. Antibiotics as part of the management of severe acute
malnutrition. N Engl J Med 2013;368(5):425–35.
42. Isanaka S, Langendorf C, Berthe F, Gnegne S, Li N, Ousmane N,
Harouna S, Hassane H, Schaefer M, Adehossi E, et al. Routine
amoxicillin for uncomplicated severe acute malnutrition in children. N
Engl J Med 2016;374(5):444–53.
43. United Nations Department of Economic and Social Affairs.
Sustainable development. Goal 4. Ensure inclusive and equitable
quality education and promote lifelong learning opportunities
for all [Internet]. [cited July 7, 2020]. Available from:
https://sustainabledevelopment.un.org/sdg4.
44. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M,
Ezzati M, Grantham-McGregor S, Katz J, Martorell R, et al. Maternal
and child undernutrition and overweight in low-income and middle-






/ajcn/advance-article/doi/10.1093/ajcn/nqaa359/6124678 by guest on 31 January 2021
12 Noble et al.
45. Daniel AI, Bandsma RH, Lytvyn L, Voskuijl WP, Potani I, Heuvel Mvd.
Psychosocial stimulation interventions for children with severe acute
malnutrition: a systematic review. J Glob Health 2017;7(1):010405.
46. Grellety E, Babakazo P, Bangana A, Mwamba G, Lezama I,
Zagre NM, Ategbo EA. Effects of unconditional cash transfers on
the outcome of treatment for severe acute malnutrition (SAM): a
cluster-randomised trial in the Democratic Republic of the Congo. BMC
Med 2017;15(1):87.
47. Altmann M, Altare C, Van Der Spek N, Barbiche JC, Dodos J,
Bechir M, Aissa MA, Kolsteren P. Effectiveness of a household water,
sanitation and hygiene package on an outpatient program for severe
acute malnutrition: a pragmatic cluster-randomized controlled trial in
Chad. Am J Trop Med Hyg 2018;98(4):1005–12.
48. Doocy S, Tappis H, Villeminot N, Suk A, Kumar D, Fazal S, Grant A,
Pietzsch S. Point-of-use water treatment improves recovery rates among
children with severe acute malnutrition in Pakistan: results from a site-
randomized trial. Public Health Nutr 2018;21(16):3080–90.
49. Brenna JT, Akomo P, Bahwere P, Berkley JA, Calder PC, Jones KD,
Liu L, Manary M, Trehan I, Briend A. Balancing omega-6 and omega-
3 fatty acids in ready-to-use therapeutic foods (RUTF). BMC Med
2015;13(1):117.
50. Hsieh JC, Liu L, Zeilani M, Ickes S, Trehan I, Maleta K, Craig
C, Thakwalakwa C, Singh L, Brenna JT, et al. High-oleic ready-to-
use therapeutic food maintains docosahexaenoic acid status in severe
malnutrition. J Pediatr Gastroenterol Nutr 2015;61(1):138–43.
51. Jones KDJ, Ali R, Khasira MA, Odera D, West AL, Koster G, Akomo P,
Talbert AWA, Goss VM, Ngari M, et al. Ready-to-use therapeutic food
with elevated n-3 polyunsaturated fatty acid content, with or without
fish oil, to treat severe acute malnutrition: a randomized controlled trial.
BMC Mede 2015;13(1):93.
52. Jones KD, Hunten-Kirsch B, Laving AM, Munyi CW, Ngari M, Mikusa
J, Mulongo MM, Odera D, Nassir HS, Timbwa M, et al. Mesalazine in
the initial management of severely acutely malnourished children with
environmental enteric dysfunction: a pilot randomized controlled trial.
BMC Med 2014;12:133.
53. Archary M, Sartorius B, La Russa P, Sibaya T, Healy M, Bobat R. HIV-
infected children with severe acute malnutrition: early vs delayed art
initiation. Top Antivir Med 2017;25(1):347s.
54. Frigati L, Archary M, Rabie H, Penazzato M, Ford N. Priorities for
decreasing morbidity and mortality in children with advanced HIV
disease. Clin Infect Dis 2018;66(Suppl 2):S147–S51.
55. Kim MH, Cox C, Dave A, Draper HR, Kabue M, Schutze GE, Ahmed
S, Kazembe PN, Kline MW, Manary M. Prompt initiation of ART with
therapeutic food is associated with improved outcomes in HIV-infected
Malawian children with malnutrition. J Acquir Immune Defic Syndr
2012;59(2):173–6.
56. Njuguna IN, Cranmer LM, Otieno VO, Mugo C, Okinyi HM, Benki-
Nugent S, Richardson B, Stern J, Maleche-Obimbo E, Wamalwa
DC, et al. Urgent versus post-stabilisation antiretroviral treatment in
hospitalised HIV-infected children in Kenya (PUSH): a randomised
controlled trial. Lancet HIV 2018;5(1):e12–22.
57. Stobaugh HC, Bollinger LB, Adams SE, Crocker AH, Grise JB,
Kennedy JA, Thakwalakwa C, Maleta KM, Dietzen DJ, Manary MJ,
et al. Effect of a package of health and nutrition services on sustained
recovery in children after moderate acute malnutrition and factors
related to sustaining recovery: a cluster-randomized trial. Am J Clin
Nutr 2017;106(2):657–66.
58. Ashworth A. Efficacy and effectiveness of community-based
treatment of severe malnutrition. Food Nutr Bull 2006;27(3 Suppl):
S24–48.
59. Ashworth A, Khanum S. Fighting malnutrition from hospital to home.
Child Health Dialogue 1996;(2):6–7.
60. Heikens GT, Schofield WN, Christie CD, Gernay J, Dawson S.
The Kingston Project. III. The effects of high energy supplement
and metronidazole on malnourished children rehabilitated in the
community: morbidity and growth. Eur J Clin Nutr 1993;47(3):174–91.
61. Heikens GT, Schofield WN, Dawson S, Grantham-McGregor S.
The Kingston project. I. Growth of malnourished children during
rehabilitation in the community, given a high energy supplement. Eur J
Clin Nutr 1989;43(3):145–60.
62. Manary MJ, Ndkeha MJ, Ashorn P, Maleta K, Briend A. Home based
therapy for severe malnutrition with ready-to-use food. Arch Dis Child
2004;89(6):557–61.
63. Bahwere P, Akomo P, Mwale M, Murakami H, Banda C, Kathumba
S, Banda C, Jere S, Sadler K, Collins S. Soya, maize, and sorghum-
based ready-to-use therapeutic food with amino acid is as efficacious as
the standard milk and peanut paste-based formulation for the treatment
of severe acute malnutrition in children: a noninferiority individually
randomized controlled efficacy clinical trial in Malawi. Am J Clin Nutr
2017;106(4):1100–12.
64. Bahwere P, Balaluka B, Wells JC, Mbiribindi CN, Sadler K, Akomo
P, Dramaix-Wilmet M, Collins S. Cereals and pulse-based ready-
to-use therapeutic food as an alternative to the standard milk- and
peanut paste-based formulation for treating severe acute malnutrition: a
noninferiority, individually randomized controlled efficacy clinical trial.
Am J Clin Nutr 2016;103(4):1145–61.
65. Bahwere P, Banda T, Sadler K, Nyirenda G, Owino V, Shaba
B, Dibari F, Collins S. Effectiveness of milk whey protein-
based ready-to-use therapeutic food in treatment of severe acute
malnutrition in Malawian under-5 children: a randomised, double-blind,
controlled non-inferiority clinical trial. Matern Child Nutr 2014;10(3):
436–51.
66. Nita B, Mohan SB, Anuradha B, Iyengar SD, Sunita T, Sarmila
M, Pricilla RA, Kirti I, Sachdev HS, Mohan VR, et al. Efficacy of
three feeding regimens for home-based management of children with
uncomplicated severe acute malnutrition: a randomised trial in India.
BMJ Glob Health 2016;1(4):e000702.
67. Sigh S, Roos N, Chamnan C, Laillou A, Prak S, Wieringa FT.
Effectiveness of a locally produced, fish-based food product on
weight gain among Cambodian children in the treatment of acute
malnutrition: a randomized controlled trial. Nutrients 2018;10(7):
909.
68. Sandige H, Ndekha MJ, Briend A, Ashorn P, Manary MJ. Home-
based treatment of malnourished Malawian children with locally
produced or imported ready-to-use food. J Pediatr Gastroenterol Nutr
2004;39(2):141–6.
69. World Health Organization Child Health and Development Unit.
Integrated management of childhood illness (IMCI) [Internet]. [cited
October 14, 2020]. Available from: https://www.who.int/maternal_chi
ld_adolescent/topics/child/imci/en/.
70. World Health Organization, United Nations Children’s Fund, World
Bank Group. Nurturing care for early childhood development: a
framework for helping children survive and thrive to transform health






/ajcn/advance-article/doi/10.1093/ajcn/nqaa359/6124678 by guest on 31 January 2021
